India’s Cadila to produce up to 30 mln COVID-19 vaccine doses a month – executive
India’s Cadila Healthcare (CADI.NS) is aiming to triple monthly production of a COVID-19 vaccine candidate to as many as 30 million doses, its managing director said on Monday, as the country battles a massive wave of infections.
